Pembrolizumab for triple-negative breast cancer. Stirrups R. Lancet Oncol 2020 Mar 5. pii: S1470-2045(20)30154.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Stirrups R. Pembrolizumab for triple-negative breast cancer. Lancet Oncol 2020 Mar 5. pii: S1470-2045(20)30154.
PMID: 32145769